Endometriosis impacts as many as 10% of reproductive-age women.

In the United States alone that adds up to 5 million women and a price tag of more than $50 billion in health care costs and lost productivity annually, according to a cost study sponsored by the World Endometriosis Research Foundation.

While the disease generally is characterized by severe pelvic pain, as many as 11% of women with the disease can be
asymptomatic (Fertility and Sterility 2011;96[2]:360-5), making it difficult to make a correct and timely diagnosis.
Its causes are uncertain, no cure is available, and research long has been underfunded. Questions abound.

What is the relationship between endometriosis and infertility?
Can genetic biomarkers be used to obtain a definitive diagnosis?
What is the role of endometriosis in the development of ovarian cancer?